Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclofem for irregular uterine bleeding in implant contraceptive users
NCT03264781Phase 2Unknown
- Sponsor
- Chulalongkorn University
- Start
- Aug 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of medroxyprogesterone acetate + estradiol in abnormal uterine bleeding (AUB), sponsored by Chulalongkorn University. Status: unknown.
02
Drugs
medroxyprogesterone acetate + estradiol
03
Conditions
abnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on NCT03264781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03264781.